Zai Lab (ZLAB) Return on Invested Capital (2025 - 2026)
Zai Lab (ZLAB) posted quarterly Return on Invested Capital of 0.0% for Q1 2026, up 1.21% on a QoQ basis from 0.0% in Q4 2025.
Zai Lab (ZLAB) Return on Invested Capital (2025 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Return on Invested Capital for 2 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.
- Quarterly Return on Invested Capital changed N/A year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed N/A YoY) and the FY2025 annual result came in at 0.01%, changed N/A from the prior year.
- Return on Invested Capital improved to 0.0% in Q1 2026 per ZLAB's latest filing, from 0.0% in the prior quarter.
- Over the last five years, Return on Invested Capital for ZLAB reached as high as 0.0% in Q1 2026 and fell as low as 0.0% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |